vTv Therapeutics Inc.

NASDAQ: VTVT · Real-Time Price · USD
15.12
1.09 (7.77%)
At close: Aug 15, 2025, 12:50 PM

vTv Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-22.7M -20.25M -25.07M -17.73M
Depreciation & Amortization
89K 90K 92K 89K
Stock-Based Compensation
2.76M 1.58M 1.27M 2.36M
Other Working Capital
-263K 1.39M 6.36M -1M
Other Non-Cash Items
-10K -4.89M 2.3M -4.06M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-5.44M 4.39M 5.38M 35K
Operating Cash Flow
-25.31M -19.08M -16.02M -19.31M
Capital Expenditures
n/a n/a -21K n/a
Cash Acquisitions
n/a 4.4M n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 4.4M n/a n/a
Other Investing Acitivies
n/a -4.4M n/a n/a
Investing Cash Flow
n/a 4.4M -21K n/a
Debt Repayment
-191K -33K -32K 172K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 47K
Financial Cash Flow
52.61M 12M 14.75M 26.98M
Net Cash Flow
27.3M -2.68M -1.29M 7.67M
Free Cash Flow
-25.31M -19.08M -16.04M -19.31M